RENAL MEDULLARY CARCINOMA
Clinical trials for RENAL MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare, aggressive cancers as national trial tests promising drug duo
Disease control Recruiting nowThis study is testing whether two existing cancer drugs, sacituzumab govitecan and atezolizumab, can help control rare and aggressive cancers of the bladder, urinary tract, kidney, and penis. The trial will enroll 60 adults to receive one or both drugs, given through an IV, to se…
Matched conditions: RENAL MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for rare kidney cancers: testing a powerful drug duo
Disease control Recruiting nowThis study is testing whether a combination of two drugs, pembrolizumab and enfortumab vedotin, can help control two rare and aggressive types of kidney cancer. It will enroll about 23 adults with advanced collecting duct carcinoma or renal medullary carcinoma. The main goal is t…
Matched conditions: RENAL MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC